Skip to content
Fiscal Receipts

Senate LDA lobbying filing

ABBOTT LABORATORIES

Registrant: MARSHALL & POPP, LLC Year: 2025 Period: Fourth Quarter Type: Q4

View on lda.senate.gov ↗

Reported income

$60.0K

Reported expenses

not reported

Tracked program mentions1

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

  • SPQ-9B Radar2026matched: “2026PE code cited directly

    Issues related to infant formula, including: H.R.4121 - Agriculture, Rural Development, Food and Drug Administration…

Lobbying activities2

  • AgricultureAGR

    Issues related to infant formula, including: H.R.4121 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; H.R. 2300 - To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes; and H.R. 5371 - Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026.

  • Medicare/MedicaidMMM

    Proposals related to Medicare coverage of continuous glucose monitors.

Lobbyists4

  • HAZEN MARSHALL
  • HAZEN MARSHALLrevolving door

    Policy Director-Senate Majority Leader Mitch McConnell; Staff Director, Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don Nickles

  • MONICA POPP
  • MONICA POPPrevolving door

    Chief of Staff/Deputy Chief of Staff, Office of Senate Republican Whip John Cornyn; Professional Staff Member, U.S. House of Representatives-Energy & Commerce Committee; Legislative Assistant, Senator Jim DeMint

Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.